Yderligere effektrapporter fra to kliniske undersøgelser (P176 og P072- 02; dobbeltblinde, randomiserede, placebokontrollerede, parallelgrupper) blev fremlagt for både formuleringen 4 mg oralt granulat og tyggetabletter.
Further efficacy reports of two clinical 11 studies (P176 and P072-02; double-blind, randomized, placebo-controlled, parallel group) were presented for both 4mg OG and CT formulations.